◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
欧林生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
+Revenue 589.0M 496.0M 547.0M 487.0M 320.0M 179.0M 76.3M 14.6M 161,300 419,300 170,200 498,200
Revenue Growth % 18.8% -9.3% 12.3% 52.2% 78.8% 134.5% 423.1% 8946.9% -61.5% 146.4% -65.8% --
Total Revenue 589.0M 496.0M 547.0M 487.0M 320.0M 179.0M 76.3M 14.6M 161,300 419,300 170,200 498,200
Cost Of Revenue 32.7M 32.0M 39.1M 29.6M 15.6M 15.2M 11.7M 2.9M 900.00 2,800 800.00 3,800
+Gross Profit 556.3M 464.0M 507.9M 457.4M 304.4M 163.8M 64.7M 11.7M 160,400 416,500 169,400 494,400
Gross Margin % 94.4% 93.5% 92.9% 93.9% 95.1% 91.5% 84.7% 80.1% 99.4% 99.3% 99.5% 99.2%
Total Operating Cost 577.0M 497.0M 534.0M 393.0M 293.0M 216.0M 99.1M 46.6M 56.8M 56.7M 30.7M 24.2M
Selling Expenses 303.0M 258.0M 288.0M 246.0M 184.0M 99.6M 30.9M 6.1M -- -- -- --
Admin Expenses 86.4M 78.3M 63.7M 50.8M 40.0M 48.9M 22.1M 16.4M 54.9M 53.6M 27.3M 21.2M
Rd Expenses 134.0M 115.0M 122.0M 56.4M 42.7M 44.1M 30.6M 19.5M -- -- -- --
Finance Expenses 10.0M 4.7M 1.3M -59,900 607,300 725,000 403,900 22,900 784,100 3.1M 3.3M 3.0M
+Operating Income 21.3M 3.1M 41.6M 102.0M 33.1M -33.2M -21.2M -28.5M -56.7M -56.2M -30.5M -23.7M
Operating Margin % 3.6% 0.6% 7.6% 20.9% 10.4% -18.5% -27.8% -195.5% -35125.5% -13413.3% -17927.9% -4756.7%
Non Operating Income 1.1M 12.6M 2.6M 5.6M 3.3M 2.2M 2.3M 1.3M 1.1M 3.9M 271,900 462,100
Non Operating Expenses 147,000 32,100 531,700 23,300 324,400 76,700 22,000 -- 2,100 31,800 -- --
Investment Income 855,600 1.0M 3.7M 3.8M 215,100 938,700 178,800 400,600 -- -- -- --
Asset Disposal Income -31,000 -149,500 -147,000 -47,900 -- -- -- -- -- -- -- --
Asset Impairment Loss -2.9M 4.7M 3.9M -1.2M 2.3M 1.0M 1.8M 400,600 8,400 1,700 1,300 1,300
Other Income 9.1M 3.3M 24.8M 4.0M 5.6M 2.5M 1.3M 3.1M -- -- -- --
Income Before Tax 22.3M 15.6M 43.6M 107.0M 36.1M -31.0M -19.0M -27.2M -55.5M -52.4M -30.2M -23.2M
Income Tax 6.6M 4.2M 17.1M -773,600 -- 33,100 19,500 31,800 -- -- -- --
+Net Income 15.7M 11.4M 26.6M 108.0M 36.1M -31.0M -19.0M -27.2M -55.5M -52.4M -30.2M -23.2M
Net Margin % 2.7% 2.3% 4.9% 22.2% 11.3% -17.3% -24.9% -186.7% -34427.0% -12486.3% -17768.2% -4663.9%
Net Income Attributable 20.8M 17.6M 26.6M 108.0M 36.1M -31.0M -19.0M -27.2M -55.5M -52.4M -30.2M -23.2M
Minority Interest -5.0M -6.1M -- -- -- -- -- -- -- -- -- --
Eps Basic 0.05 0.04 0.07 0.28 0.10 -0.09 -0.09 -0.13 -0.29 -0.31 -0.22 -0.17
Eps Diluted 0.05 0.04 0.07 0.28 0.10 -0.09 -0.09 -0.13 -0.29 -0.31 -0.22 --
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
Cash And Equivalents 224.0M 362.0M 269.0M 254.0M 104.0M 95.6M 11.5M 6.5M 4.0M 57.0M 2.4M 22.3M
Trading Financial Assets 17.5M 100.00 90.0M 200.0M 10.0M -- -- -- -- -- -- --
Accounts Receivable 566.0M 491.0M 491.0M 337.0M 191.0M 111.0M 37.6M 7.1M -- -- 3,000 --
Notes Receivable 3.9M 300,000 521,800 5.5M 1.6M 3.5M -- 19.2M -- -- -- --
Notes And Accounts Receivable 570.0M 492.0M 492.0M 343.0M 192.0M 115.0M 37.6M 26.3M -- -- 3,000 --
Prepayments 9.1M 4.2M 2.3M 2.3M 5.7M 3.4M 4.4M 4.7M 3.9M 5.0M 8.8M 24.1M
Inventory 85.7M 72.1M 78.5M 74.5M 46.0M 33.9M 22.6M 15.8M 1.2M 1.2M 566,200 --
Total Current Assets 908.0M 931.0M 936.0M 875.0M 363.0M 250.0M 77.2M 73.9M 9.2M 64.2M 14.9M 48.0M
Fixed Assets -- 239.0M 234.0M 241.0M -- 193.0M 174.0M 175.0M 178.0M 178.0M 185.0M 116.0M
Fixed Assets Total 359.0M 239.0M 234.0M 241.0M 235.0M 193.0M 174.0M 175.0M 178.0M 178.0M 185.0M 116.0M
Construction In Progress -- 181.0M 135.0M 11.6M 5.3M 6.0M 16.3M 7.4M 701,400 5.7M 502,400 45.2M
Construction In Progress Total 211.0M 181.0M 135.0M 11.6M 5.3M 6.0M 16.3M 7.4M 701,400 5.7M 502,400 45.2M
Intangible Assets 16.3M 16.8M 17.5M 13.8M 12.2M 11.9M 12.3M 12.6M 12.9M 13.2M 13.4M 13.5M
Long Term Deferred Expenses 8.6M 9.7M 10.8M 10.7M 2.2M 658,600 724,900 1.6M 2.8M 4.1M 5.2M 5.9M
Total Non Current Assets 899.0M 681.0M 543.0M 337.0M 278.0M 238.0M 205.0M 197.0M 195.0M 201.0M 204.0M 181.0M
Total Assets 1.8B 1.6B 1.5B 1.2B 641.0M 488.0M 282.0M 271.0M 204.0M 265.0M 219.0M 229.0M
Short Term Borrowings 24.2M 24.2M 85.0M 35.0M 25.0M 5.0M 20.0M -- -- -- 5.0M --
Accounts Payable 86.3M 40.1M 75.9M 34.3M 33.1M 13.6M 6.3M 6.2M 13.2M 14.9M 15.8M 8.7M
Advance Receipts -- -- -- -- -- 13.4M 16.7M 33.1M 3.0M 2.9M 853,300 855,000
Contract Liabilities 510,900 3.6M 6.7M 7.5M 2.6M -- -- -- -- -- -- --
Total Current Liabilities 596.0M 476.0M 525.0M 342.0M 240.0M 138.0M 85.2M 52.6M 18.5M 54.7M 28.5M 18.9M
Long Term Borrowings 250.0M 177.0M 30.0M -- -- -- -- -- -- -- 42.0M 42.0M
Total Non Current Liabilities 278.0M 206.0M 61.8M 25.6M 24.5M 9.2M 2.7M 4.8M 5.0M 3.8M 43.0M 42.0M
Total Liabilities 874.0M 682.0M 587.0M 367.0M 264.0M 147.0M 87.9M 57.4M 23.5M 58.5M 71.5M 60.9M
Paid In Capital 406.0M 406.0M 405.0M 405.0M 365.0M 365.0M 206.0M 206.0M 196.0M 189.0M 138.0M 138.0M
Capital Reserve 606.0M 606.0M 581.0M 571.0M 251.0M 251.0M 233.0M 233.0M 184.0M 161.0M 100.0M 76.0M
Surplus Reserve 14.2M 8.6M 2.7M -- -- -- -- -- -- -- -- --
Retained Earnings -95.9M -95.7M -107.0M -131.0M -239.0M -275.0M -244.0M -225.0M -199.0M -143.0M -91.1M -45.9M
Minority Equity 8.8M 13.9M 10.2M -- -- -- -- -- -- -- -- --
Equity Attributable 925.0M 917.0M 882.0M 845.0M 377.0M 341.0M 194.0M 213.0M 180.0M 207.0M 147.0M 168.0M
Total Equity 934.0M 931.0M 892.0M 845.0M 377.0M 341.0M 194.0M 213.0M 180.0M 207.0M 147.0M 168.0M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
Cash From Sales 512.0M 509.0M 387.0M 345.0M 233.0M 103.0M 50.2M 22.0M 324,800 2.4M 222,100 1.4M
Total Operating Cash Inflow 536.0M 531.0M 430.0M 362.0M 249.0M 108.0M 55.7M 28.1M 5.8M 10.3M 2.1M 1.9M
Cash Paid For Goods 65.1M 54.7M 38.3M 35.0M 47.7M 33.4M 20.3M 6.9M 7.7M 3.6M 1.5M 788,400
Cash Paid To Employees 95.9M 89.6M 90.3M 63.6M 45.3M 36.6M 23.9M 18.0M 24.0M 15.3M 9.8M 5.4M
Taxes Paid 25.6M 34.2M 35.0M 16.6M 11.9M 6.9M 4.0M 1.7M 1.2M 1.3M 1.2M 1.3M
Total Operating Cash Outflow 545.0M 487.0M 455.0M 322.0M 228.0M 150.0M 72.4M 49.6M 48.4M 37.4M 21.8M 21.2M
Operating Cash Flow -9.7M 44.0M -24.5M 40.0M 21.1M -41.8M -16.7M -21.5M -42.6M -27.0M -19.7M -19.3M
Total Investing Cash Inflow 220.0M 151.0M 469.0M 854.0M 68.2M 176.0M 20.2M 60.4M 460,000 -- 74,400 --
Total Investing Cash Outflow 444.0M 230.0M 526.0M 1.1B 117.0M 204.0M 18.1M 95.7M 6.8M 12.8M 5.7M 39.9M
Investing Cash Flow -224.0M -78.8M -57.0M -256.0M -48.6M -28.2M 2.1M -35.3M -6.4M -12.8M -5.6M -39.9M
Cash From Borrowings 207.0M 208.0M 130.0M 35.0M 25.0M 10.0M 20.0M 5.0M -- -- 8.5M --
Dividends And Interest Paid 29.7M 6.0M 4.3M 1.0M 754,700 494,000 400,300 97,000 1.0M 2.7M 3.7M 3.8M
Debt Repayments 78.8M 100.0M 40.0M 25.0M 5.0M 25.0M -- 5.0M 32.0M 15.0M 8.0M 32.3M
Total Financing Cash Inflow 207.0M 235.0M 148.0M 407.0M 26.5M 190.0M 20.0M 65.0M 30.0M 142.0M 13.4M 117.0M
Total Financing Cash Outflow 111.0M 106.0M 44.3M 38.0M 8.1M 36.3M 400,300 5.7M 34.0M 47.7M 11.8M 36.1M
Financing Cash Flow 95.9M 129.0M 103.0M 369.0M 18.4M 154.0M 19.6M 59.3M -4.0M 94.4M 1.5M 80.5M
Net Change In Cash -138.0M 94.4M 21.8M 153.0M -9.2M 84.2M 5.0M 2.5M -53.0M 54.6M -23.8M 21.3M
Ending Cash Balance 218.0M 356.0M 261.0M 239.0M 86.4M 95.6M 11.5M 6.5M 4.0M 57.0M 2.4M 22.3M
Capex 207.0M 170.0M 201.0M 69.7M 38.8M 29.2M 18.1M 15.7M 6.8M 12.8M 5.7M 39.9M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...